E-Cigarettes Spark Evolution Of FDA’s Nicotine-Containing Medical Product Regulation
This article was originally published in The Tan Sheet
Executive Summary
FDA’s tobacco, drug and medical device centers are discussing “some sort of jurisdictional policy” to “determine how to evolve the regulation of therapeutic nicotine products,” including OTC drugs, says tobacco program head Mitch Zeller.